iShares Genomics Immunology and Healthcare ETF (IDNA)
- Previous Close
21.94 - Open
22.01 - Bid 21.28 x 1000
- Ask 27.61 x 1100
- Day's Range
21.95 - 22.38 - 52 Week Range
17.33 - 25.52 - Volume
17,773 - Avg. Volume
37,974 - Net Assets 140.9M
- NAV 22.31
- PE Ratio (TTM) 2.18
- Yield 1.00%
- YTD Daily Total Return -3.09%
- Beta (5Y Monthly) 1.15
- Expense Ratio (net) 0.47%
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
iShares
Fund Family
Health
Fund Category
140.9M
Net Assets
2019-06-11
Inception Date
Performance Overview: IDNA
Trailing returns as of 4/26/2024. Category is Health.
People Also Watch
Holdings: IDNA
Top 10 Holdings (42.27% of Total Assets)
Sector Weightings
Related ETF News
Research Reports: IDNA
ERF: What does Argus have to say about ERF?
ENERPLUS CORP has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetAnalyst Report: Sociedad Química y Minera de Chile S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM is also developing a hard rock lithium project in Australia and is growing its lithium refining assets in China.
RatingPrice TargetAnalyst Report: Lithium Americas Corp.
Lithium Americas is a pure-play lithium producer. The firm owns one resource, Thacker Pass, that is located in northwest Nevada. Thacker Pass recently began construction and is expected to begin production in the mid-2020s. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.
RatingPrice TargetAnalyst Report: Albemarle Corporation
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the U.S. and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the U.S., Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
RatingPrice Target